The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
100400326 10040032 6 F 20140317 20141223 20140326 20141231 EXP TR-JNJFOC-20140316322 PHARMACYCLICS 79.00 YR E M Y 69.00000 KG 20141231 N MD TR TR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
100400326 10040032 1 PS IBRUTINIB IBRUTINIB 1 ORAL N L0307805B;L0404313G 0 280 MG CAPSULE QD
100400326 10040032 2 SS IBRUTINIB IBRUTINIB 1 ORAL 51660 MG N L0307805B;L0404313G 205552 420 MG CAPSULE QD
100400326 10040032 3 SS IBRUTINIB IBRUTINIB 1 ORAL N L0307805B;L0404313G 102688 420 MG CAPSULE QD
100400326 10040032 4 C ARLEC 2 ORAL D L0309805B 0 6.2 MG QD
100400326 10040032 5 C ARLEC 2 ORAL D L0309805B 0 420 MG QD
100400326 10040032 6 C ARLEC 2 ORAL D L0309805B 0 6.2 MG QD
100400326 10040032 7 C LOTEMAX LOTEPREDNOL ETABONATE 1 OPHTHALMIC 1 DROP PER DAY D 0 DROPS
100400326 10040032 8 C DELIX RAMIPRIL 1 ORAL D 0 16 MG QD
100400326 10040032 9 C ASPIRIN. ASPIRIN 1 ORAL D 0 100 MG QD
100400326 10040032 10 C VIGAMOX MOXIFLOXACIN HYDROCHLORIDE 1 OPHTHALMIC D 0 DROPS
100400326 10040032 11 C ALDACTONE SPIRONOLACTONE 1 ORAL D 0 2.5 MG QD
100400326 10040032 12 C DESAL FUROSEMIDE 1 ORAL D 0 40 MG QD
100400326 10040032 13 C URIKOLIZ ALLOPURINOL 1 ORAL D 0 300 MG QD
100400326 10040032 14 C OMEPRAZOLE. OMEPRAZOLE 1 ORAL D 0 20 MG QD
100400326 10040032 15 C BETALOC ZOK METOPROLOL SUCCINATE 1 ORAL D 0 25 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
100400326 10040032 1 Chronic lymphocytic leukaemia
100400326 10040032 2 Chronic lymphocytic leukaemia
100400326 10040032 3 Chronic lymphocytic leukaemia
100400326 10040032 4 Coronary artery disease
100400326 10040032 5 Coronary artery disease
100400326 10040032 6 Coronary artery disease
100400326 10040032 7 Corneal decompensation
100400326 10040032 8 Coronary artery disease
100400326 10040032 9 Coronary artery disease
100400326 10040032 10 Corneal decompensation
100400326 10040032 11 Coronary artery disease
100400326 10040032 12 Coronary artery disease
100400326 10040032 13 Oedema
100400326 10040032 14 Gastric disorder
100400326 10040032 15 Cardiac failure

Outcome of event

Event ID CASEID OUTC COD
100400326 10040032 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
100400326 10040032 Cardiac failure

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
100400326 10040032 1 20140402 0
100400326 10040032 2 20131001 20140317 0
100400326 10040032 3 20140324 0
100400326 10040032 4 201004 0
100400326 10040032 5 20140324 0
100400326 10040032 6 201004 0
100400326 10040032 7 2003 0
100400326 10040032 8 201004 0
100400326 10040032 9 201004 0
100400326 10040032 10 2003 0
100400326 10040032 11 201004 0
100400326 10040032 12 201004 0
100400326 10040032 13 20140208 0
100400326 10040032 14 20140210 0
100400326 10040032 15 20140218 0